USPTO serial 99743798
RELFY
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- ONUOHA, ALEXANDRIA N
- Law office
- TMO LAW OFFICE 113
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with RELFY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Katherine P. Califa
Katherine P. Califa Foley & Lardner LLP3000 K Street, N.W. Suite 600Washington, DC 20007United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in dermatology; pharmaceutical preparations containing neurotoxins for use in dermatology; dermatological preparations; pre-filled syringes for medical purposes; injectable neurotoxins; medicated dermatological preparations and substances for the treatment of wrinkles, folds, scars, and lips, for face and body contour and skin rejuvenation; medicinal preparations for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; pharmaceutical preparations containing neurotoxins for the treatment of bags under the eyes, dark circles, wrinkles, excess fat, tired and droopy eyes, loss of facial volume, sunken cheeks, reduced facial contours and structure, reduced skin quality, sun spots; injectable pharmaceutical products, namely, injectable dermal filler; injectable gels for use in the treatment and repair of joint cartilage; injectable dermal filler products, namely, injectable dermal fillers; pharmaceutical preparations containing neurotoxins for skin care; muscle relaxants; pharmaceutical preparations for the treatment of neurological disorders, muscle dystonia, headaches, wrinkles, hyperhidrosis, and pain | ACTIVE | — |
| 010 | Medical devices, namely, implants consisting of artificial materials in gel form used for filling wrinkles, folds, scars, lips, for face and body contour and skin rejuvenation; syringes for injections; injection devices for pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 20, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 13, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 30, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 3, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 3, 2026 | NWAP | NEW APPLICATION ENTERED | — |